| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 1,897 | 2,182 | ||
| General and administrative | 1,855 | 1,802 | ||
| Loss on impairment of intangible assets | 16,130 | - | ||
| Total operating expenses | 19,882 | 3,984 | ||
| Operating loss | - | -3,984 | ||
| Gain on debt extinguishment, net | 0 | 74 | ||
| Loss on debt issuances | - | -7,313 | ||
| Loss on deposit settlement | -650 | - | ||
| Change in fair value of convertible notes payable | 2,684 | 785 | ||
| Change in fair value of common stock warrant liability | -50 | -108 | ||
| Other expense, net | - | -420 | ||
| Change in fair value of derivative liabilities | 613 | - | ||
| Interest income | 758 | 198 | ||
| Change in fair value of derivative liabilities | - | 0 | ||
| Interest expense | 328 | 79 | ||
| Total other (expense) income, net | -11,634 | -6,647 | ||
| Loss before income taxes | -31,516 | -10,631 | ||
| Income tax benefit (expense) | -3,431 | 0 | ||
| Net loss | -28,085 | -10,631 | ||
| Extinguishment of series b preferred stock | 0 | - | ||
| Dividends on preferred stock-Series CPreferred Stock | 650 | 4,141 | ||
| Dividends on preferred stock-Series DPreferred Stock | 203 | 137 | ||
| Deemed dividends on warrants | 0 | 9 | ||
| Net loss attributable to common stockholders | -28,938 | -14,918 | ||
| Basic and diluted (in dollars per share) | -1.08 | -3.06 | ||
| Basic and diluted (in shares) | 26,675,559 | 4,877,257 | ||
WINDTREE THERAPEUTICS INC DE (WINT)
WINDTREE THERAPEUTICS INC DE (WINT)